FORTREA SELECTS COGNIZANT AS ITS TECHNOLOGY TRANSFORMATION PROVIDER
TEANECK, N.J. and DURHAM, N.C., Jan. 4, 2024 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) and Fortrea (Nasdaq: FTRE), a leading global provider of clinical development and patient access solutions to the life sciences industry, today announced that Cognizant has been selected as Fortrea's strategic technology transformation provider.
- Cognizant to help Fortrea deploy a modern, secure digital ecosystem to help bring treatments to patients faster
TEANECK, N.J. and DURHAM, N.C., Jan. 4, 2024 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) and Fortrea (Nasdaq: FTRE), a leading global provider of clinical development and patient access solutions to the life sciences industry, today announced that Cognizant has been selected as Fortrea's strategic technology transformation provider. - Over the four-year agreement, Cognizant is expected to transform Fortrea's global technology environment.
- "Today's announcement reflects Fortrea's renewed organizational agility following our spin-off," said Alejandro Martinez Galindo, Chief Information Officer of Fortrea.
- "Cognizant is proud to partner with Fortrea as they leverage technology to build a world-class culture of excellence that benefits customers, patients, employees and shareholders," said Cognizant EVP, Software and Platform Engineering, Prasad Sankaran.